Phoenix Group Holdings plc

BATS-CHIXE:PHNXL Stock Report

Market Cap: UK£5.6b

Phoenix Group Holdings Valuation

Is PHNXL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PHNXL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PHNXL (£5.59) is trading below our estimate of fair value (£8.28)

Significantly Below Fair Value: PHNXL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHNXL?

Other financial metrics that can be useful for relative valuation.

PHNXL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.009x
Enterprise Value/EBITDA0.6x
PEG Ration/a

Price to Sales Ratio vs Peers

How does PHNXL's PS Ratio compare to its peers?

The above table shows the PS ratio for PHNXL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.2x
LGEN Legal & General Group
1.1x6.9%UK£13.2b
JUST Just Group
0.4x21.7%UK£1.4b
PRU Prudential
2.3x26.2%UK£18.7b
CSN Chesnara
0.9xn/aUK£385.0m
PHNXL Phoenix Group Holdings
0.2x-27.2%UK£5.6b

Price-To-Sales vs Peers: PHNXL is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1.2x).

Price to Earnings Ratio vs Industry

How does PHNXL's PE Ratio compare vs other companies in the GB Insurance Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.3%
 n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.3%
 n/an/an/a
No more companies

Price-To-Sales vs Industry: PHNXL is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Insurance industry average (0.9x).

Price to Sales Ratio vs Fair Ratio

What is PHNXL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHNXL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: PHNXL is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PHNXL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£5.59
UK£5.99
+7.1%
10.9%UK£7.43UK£5.10n/a14
Sep ’25UK£5.67
UK£6.05
+6.7%
11.5%UK£7.43UK£5.00n/a13
Aug ’25UK£5.40
UK£6.00
+11.0%
11.6%UK£7.43UK£5.00n/a14
Jul ’25UK£5.32
UK£6.02
+13.1%
12.0%UK£7.43UK£5.00n/a14
Jun ’25UK£4.97
UK£6.04
+21.5%
11.5%UK£7.43UK£5.00n/a14
May ’25UK£4.84
UK£6.02
+24.3%
11.3%UK£7.43UK£5.00n/a14
Apr ’25UK£5.50
UK£6.04
+9.8%
13.6%UK£7.43UK£4.45n/a14
Mar ’25UK£5.03
UK£5.98
+18.9%
13.9%UK£7.43UK£4.45n/a14
Feb ’25UK£5.01
UK£5.98
+19.4%
14.2%UK£7.43UK£4.35n/a14
Jan ’25UK£5.34
UK£5.81
+8.8%
14.9%UK£7.43UK£4.15n/a13
Dec ’24UK£4.68
UK£5.84
+24.8%
15.2%UK£7.43UK£4.00n/a13
Nov ’24UK£4.57
UK£6.04
+32.2%
13.8%UK£7.43UK£4.30n/a13
Oct ’24UK£4.82
UK£6.52
+35.3%
12.0%UK£7.55UK£5.00UK£5.5914
Sep ’24UK£5.22
UK£6.69
+28.2%
9.9%UK£7.70UK£5.60UK£5.6714
Aug ’24UK£5.45
UK£6.92
+26.9%
8.6%UK£8.00UK£5.80UK£5.4014
Jul ’24UK£5.33
UK£7.06
+32.6%
8.5%UK£8.30UK£6.27UK£5.3215
Jun ’24UK£5.54
UK£7.13
+28.7%
9.1%UK£8.30UK£6.27UK£4.9715
May ’24UK£5.94
UK£7.16
+20.6%
8.7%UK£8.30UK£6.27UK£4.8415
Apr ’24UK£5.47
UK£7.11
+30.0%
9.0%UK£8.30UK£6.27UK£5.5016
Mar ’24UK£6.37
UK£7.27
+14.1%
9.6%UK£8.60UK£6.35UK£5.0316
Feb ’24UK£6.36
UK£7.29
+14.6%
9.7%UK£8.60UK£6.35UK£5.0116
Jan ’24UK£6.11
UK£7.26
+18.8%
9.5%UK£8.60UK£6.35UK£5.3417
Dec ’23UK£5.94
UK£7.32
+23.2%
9.5%UK£8.40UK£6.15UK£4.6816
Nov ’23UK£5.47
UK£7.29
+33.4%
9.0%UK£8.40UK£6.30UK£4.5717
Oct ’23UK£5.27
UK£7.45
+41.3%
9.1%UK£8.40UK£6.30UK£4.8217

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y